{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:48:40Z","timestamp":1787021320354,"version":"build-2736575974"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012330","name":"Okayama University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012330","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Angiogenesis is essential for tumor progression. Microvessel density (MVD) is a widely used histological method to assess angiogenesis using immunostained sections, but its prognostic significance in esophageal cancer remains controversial. Recently, the evaluation of microvascular architecture has gained importance as a method to assess tumor aggressiveness. The present study aimed to identify the histological characteristics of tumor microvessels that are associated with the aggressiveness of esophageal squamous cell carcinoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>A total of 108 esophageal squamous cell carcinoma tissues were immunohistochemically stained with blood vessel markers and angiogenesis-related markers, including CD31, alpha smooth muscle actin, vascular endothelial growth factor A (VEGF-A), CD206, and D2-40. MVD, microvessel pericyte coverage index (MPI), and tumor vascular morphology were evaluated by microscopy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>MVD was significantly associated with patient outcomes, whereas neither MPI nor VEGF-A expression throughout the tumor showed a significant correlation. In addition, the presence of blood vessels encircling clusters of tumor cells, termed C-shaped microvessels, and excessively branching microvessels, termed X-shaped microvessels, was significantly associated with poor prognosis. These vessel types were also correlated with clinicopathological parameters, including deeper invasion of the primary tumor, presence of lymph node metastasis, advanced pathological stage, and distant metastasis. Focal VEGF-A immunoexpression in tumor cells was higher in areas containing C-shaped or X-shaped microvessels compared with areas lacking these vessel morphologies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The data suggest that tumor microvessels with specific morphologies (C-shaped and X-shaped microvessels) may serve as a promising prognostic factor in esophageal squamous cell carcinoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-025-17747-2","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T16:09:59Z","timestamp":1752163799000},"page":"8024-8036","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tumor Microvessels with Specific Morphology as a Prognostic Factor in Esophageal Squamous Cell Carcinoma"],"prefix":"10.1245","volume":"32","author":[{"given":"Hnin Thida","family":"Tun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4794-4837","authenticated-orcid":false,"given":"Masayoshi","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seitaro","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyoshi","family":"Kunitomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Noma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Matsukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"issue":"11","key":"17747_CR1","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/1759-7714.14835","volume":"14","author":"H Zhu","year":"2023","unstructured":"Zhu H, Wang Z, Deng B, et al. Epidemiological landscape of esophageal cancer in Asia: results from GLOBOCAN 2020. Thorac Cancer. 2023;14(11):992\u20131003.","journal-title":"Thorac Cancer."},{"issue":"3","key":"17747_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin."},{"issue":"3","key":"17747_CR3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10388-023-00993-2","volume":"20","author":"Y Kitagawa","year":"2023","unstructured":"Kitagawa Y, Ishihara R, Ishikawa H, et al. Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1. Esophagus. 2023;20(3):343\u201372.","journal-title":"Esophagus."},{"issue":"1","key":"17747_CR4","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin."},{"issue":"2","key":"17747_CR5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ydbio.2012.09.018","volume":"372","author":"D Ribatti","year":"2012","unstructured":"Ribatti D, Crivellato E. \u201cSprouting angiogenesis\u201d, a reappraisal. Dev Biol. 2012;372(2):157\u201365.","journal-title":"Dev Biol."},{"key":"17747_CR6","doi-asserted-by":"crossref","first-page":"175586","DOI":"10.1016\/j.ejphar.2023.175586","volume":"949","author":"S Ghalehbandi","year":"2023","unstructured":"Ghalehbandi S, Yuzugulen J, Pranjol MZI, Pourgholami MH. The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF. Eur J Pharmacol. 2023;949:175586.","journal-title":"Eur J Pharmacol."},{"issue":"12","key":"17747_CR7","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nrc3627","volume":"13","author":"HL Goel","year":"2013","unstructured":"Goel HL, Mercurio AM. VEGF targets the tumour cell. Nat Rev Cancer. 2013;13(12):871\u201382.","journal-title":"Nat Rev Cancer."},{"issue":"4","key":"17747_CR8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/PPO.0000000000000138","volume":"21","author":"DR Bielenberg","year":"2015","unstructured":"Bielenberg DR, Zetter BR. The contribution of angiogenesis to the process of metastasis. Cancer J. 2015;21(4):267\u201373.","journal-title":"Cancer J."},{"key":"17747_CR9","volume":"13","author":"J Gao","year":"2022","unstructured":"Gao J, Liang Y, Wang L. Shaping polarization of tumor-associated macrophages in cancer immunotherapy. Front Immunol. 2022;13:888713.","journal-title":"Front Immunol."},{"issue":"3","key":"17747_CR10","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ijrobp.2004.07.694","volume":"61","author":"RL Foote","year":"2005","unstructured":"Foote RL, Weidner N, Harris J, et al. Evaluation of tumor angiogenesis measured with microvessel density (MVD) as a prognostic indicator in nasopharyngeal carcinoma: results of RTOG 9505. Int J Radiat Oncol Biol Phys. 2005;61(3):745\u201353.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"17747_CR11","first-page":"1388","volume":"60","author":"A Eberhard","year":"2000","unstructured":"Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies 1. Cancer Res. 2000;60:1388\u201393.","journal-title":"Cancer Res."},{"issue":"29","key":"17747_CR12","volume":"96","author":"G Ma","year":"2017","unstructured":"Ma G, Zhang J, Jiang H, et al. Microvessel density as a prognostic factor in esophageal squamous cell cancer patients. Medicine (Baltimore). 2017;96(29):e7600.","journal-title":"Medicine (Baltimore)."},{"issue":"12","key":"17747_CR13","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/sj.bjc.6603176","volume":"94","author":"G Des Guetz","year":"2006","unstructured":"Des Guetz G, Uzzan B, Nicolas P, et al. Microvessel density and VEGF expression are prognostic factors in colorectal cancer meta-analysis of the literature. Br J Cancer. 2006;94(12):1823\u201332.","journal-title":"Br J Cancer."},{"issue":"9","key":"17747_CR14","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1158\/0008-5472.CAN-03-1957","volume":"64","author":"B Uzzan","year":"2004","unstructured":"Uzzan B, Nicolas P, Cucherat M, Perret GY. Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res. 2004;64(9):2941\u201355.","journal-title":"Cancer Res."},{"issue":"7","key":"17747_CR15","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1158\/1055-9965.EPI-12-0020","volume":"21","author":"M Chen","year":"2012","unstructured":"Chen M, Cai E, Huang J, Yu P, Li K. Prognostic value of vascular endothelial growth factor expression in patients with esophageal cancer: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2012;21(7):1126\u201334.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"2","key":"17747_CR16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000087840","volume":"69","author":"Y Yonenaga","year":"2005","unstructured":"Yonenaga Y, Mori A, Onodera H, et al. Absence of smooth muscle actin-positive pericyte coverage of tumor vessels correlates with hematogenous metastasis and prognosis of colorectal cancer patients. Oncology. 2005;69(2):159\u201366.","journal-title":"Oncology."},{"issue":"2","key":"17747_CR17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.clbc.2015.09.002","volume":"16","author":"S Shrivastav","year":"2016","unstructured":"Shrivastav S, Bal A, Singh G, Joshi K. Tumor angiogenesis in breast cancer: pericytes and maturation does not correlate with lymph node metastasis and molecular subtypes. Clin Breast Cancer. 2016;16(2):131\u20138.","journal-title":"Clin Breast Cancer."},{"issue":"6","key":"17747_CR18","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.bjc.6604929","volume":"100","author":"JA Nagy","year":"2009","unstructured":"Nagy JA, Chang SH, Dvorak AM, Dvorak HF. Why are tumour blood vessels abnormal and why is it important to know? Br J Cancer. 2009;100(6):865\u20139.","journal-title":"Br J Cancer."},{"issue":"1","key":"17747_CR19","doi-asserted-by":"crossref","first-page":"13797","DOI":"10.1038\/s41598-018-32139-1","volume":"8","author":"IC Wu","year":"2018","unstructured":"Wu IC, Syu HY, Jen CP, et al. Early identification of esophageal squamous neoplasm by hyperspectral endoscopic imaging. Sci Rep. 2018;8(1):13797.","journal-title":"Sci Rep."},{"issue":"2","key":"17747_CR20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10388-016-0527-7","volume":"14","author":"T Oyama","year":"2017","unstructured":"Oyama T, Inoue H, Arima M, et al. Prediction of the invasion depth of superficial squamous cell carcinoma based on microvessel morphology: magnifying endoscopic classification of the Japan Esophageal Society. Esophagus. 2017;14(2):105\u201312.","journal-title":"Esophagus."},{"issue":"1","key":"17747_CR21","doi-asserted-by":"crossref","first-page":"6744","DOI":"10.1038\/s41598-023-34026-w","volume":"13","author":"K Washimi","year":"2023","unstructured":"Washimi K, Kasajima R, Shimizu E, et al. Histological markers, sickle-shaped blood vessels, myxoid area, and infiltrating growth pattern help stratify the prognosis of patients with myxofibrosarcoma\/undifferentiated sarcoma. Sci Rep. 2023;13(1):6744.","journal-title":"Sci Rep."},{"issue":"5","key":"17747_CR22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7150\/jca.8716","volume":"5","author":"M Senchukova","year":"2014","unstructured":"Senchukova M, Kiselevsky MV. The \u201ccavitary\u201d type of angiogenesis by gastric cancer. Morphological characteristics and prognostic value. J Cancer. 2014;5(5):311\u20139.","journal-title":"J Cancer."},{"issue":"7","key":"17747_CR23","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/pin.13442","volume":"74","author":"HWW Swe","year":"2024","unstructured":"Swe HWW, Fujisawa M, Ohara T, et al. The specific shapes of capillaries are associated with worse prognosis in patients with invasive breast cancer. Pathol Int. 2024;74(7):394\u2013407.","journal-title":"Pathol Int."},{"issue":"1","key":"17747_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-019-0478-4","volume":"17","author":"DA Annan","year":"2019","unstructured":"Annan DA, Maishi N, Soga T, et al. Carbonic anhydrase 2 (CAII) supports tumor blood endothelial cell survival under lactic acidosis in the tumor microenvironment. Cell Commun Signal. 2019;17(1):1\u201315.","journal-title":"Cell Commun Signal."},{"issue":"3","key":"17747_CR25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41416-018-0157-z","volume":"119","author":"I Ruscito","year":"2018","unstructured":"Ruscito I, Cacsire Castillo-Tong D, Vergote I, et al. Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study). Br J Cancer. 2018;119(3):330\u20138.","journal-title":"Br J Cancer."},{"issue":"6","key":"17747_CR26","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.jtcvs.2003.12.034","volume":"127","author":"MH Kulke","year":"2004","unstructured":"Kulke MH, Odze RD, Mueller JD, Wang H, Redston M, Bertagnolli MM. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer. J Thorac Cardiovasc Surg. 2004;127(6):1579\u201386.","journal-title":"J Thorac Cardiovasc Surg."},{"issue":"1","key":"17747_CR27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1267\/ahc.20-00032","volume":"54","author":"K Cizkova","year":"2021","unstructured":"Cizkova K, Foltynkova T, Gachechiladze M, Tauber Z. Comparative analysis of immunohistochemical staining intensity determined by light microscopy, imagej and qupath in placental hofbauer cells. Acta Histochem Cytochem. 2021;54(1):21\u20139.","journal-title":"Acta Histochem Cytochem."},{"key":"17747_CR28","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.3389\/fonc.2019.01512","volume":"9","author":"SD Jayasingam","year":"2020","unstructured":"Jayasingam SD, Citartan M, Thang TH, Mat Zin AA, Ang KC, Ch\u2019ng ES. Evaluating the polarization of tumor-associated macrophages into M1 and M2 phenotypes in human cancer tissue: technicalities and challenges in routine clinical practice. Front Oncol. 2020;9:1512.","journal-title":"Front Oncol."},{"issue":"7","key":"17747_CR29","first-page":"3431","volume":"34","author":"T Sakurai","year":"2014","unstructured":"Sakurai T, Okumura H, Matsumoto M, et al. Endoglin (CD105) is a useful marker for evaluating microvessel density and predicting prognosis in esophageal squamous cell carcinoma. Anticancer Res. 2014;34(7):3431\u20138.","journal-title":"Anticancer Res."},{"issue":"9","key":"17747_CR30","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.humpath.2005.06.019","volume":"36","author":"RS Saad","year":"2005","unstructured":"Saad RS, El-Gohary Y, Memari E, Liu YL, Silverman JF. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in esophageal adenocarcinoma. Hum Pathol. 2005;36(9):955\u201361.","journal-title":"Hum Pathol."},{"issue":"8","key":"17747_CR31","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.21037\/tcr-19-2039","volume":"9","author":"W Qian","year":"2020","unstructured":"Qian W, Huang P, Liang X, Chen Y, Guan B. High expression of carcinoembryonic antigen-associated cell adhesion molecule 1 is associated with microangiogenesis in esophageal squamous cell carcinoma. Transl Cancer Res. 2020;9(8):4762\u20139.","journal-title":"Transl Cancer Res."},{"issue":"12","key":"17747_CR32","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/jcp.54.12.940","volume":"54","author":"G\u00d6 Elpek","year":"2001","unstructured":"Elpek G\u00d6, Gelen T, Aksoy NH, et al. The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus. J Clin Pathol. 2001;54(12):940\u20134.","journal-title":"J Clin Pathol."},{"issue":"7","key":"17747_CR33","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/(SICI)1097-0142(19980401)82:7<1225::AID-CNCR3>3.0.CO;2-E","volume":"82","author":"M Igarashi","year":"1998","unstructured":"Igarashi M, Dhar DK, Kubota H, Yamamoto A, El-Assal O, Nagasue N. The prognostic significance of microvessel density and thymidine phosphorylase expression in squamous cell carcinoma of the esophagus. Cancer. 1998;82(7):1225\u201332.","journal-title":"Cancer."},{"key":"17747_CR34","first-page":"2195","volume":"9","author":"Y Kitadai","year":"1998","unstructured":"Kitadai Y, Haruma K, Tokutomi T, et al. Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas. Clin Cancer Res. 1998;9:2195\u2013200.","journal-title":"Clin Cancer Res."},{"key":"17747_CR35","volume":"11","author":"L Tang","year":"2024","unstructured":"Tang L, Yin L, Mu YF, et al. Quantitative analysis of metastatic microenvironment of esophageal cancer. World Cancer Res J. 2024;11:e2785.","journal-title":"World Cancer Res J."},{"issue":"8","key":"17747_CR36","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1245\/ASO.2006.08.012","volume":"13","author":"JY Choi","year":"2006","unstructured":"Choi JY, Jang KT, Shim YM, et al. Prognostic significance of vascular endothelial growth factor expression and microvessel density in esophageal squamous cell carcinoma: Comparison with positron emission tomography. Ann Surg Oncol. 2006;13(8):1054\u201362.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"17747_CR37","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1067\/msy.2001.111122","volume":"129","author":"S Nakagawa","year":"2001","unstructured":"Nakagawa S, Nishimaki T, Suzuki T, Kanda T, Kuwabara S, Hatakeyama K. Tumor angiogenesis as an independent prognostic factor after extended radical esophagectomy for invasive squamous cell carcinoma of the esophagus. Surgery. 2001;129(3):302\u20138.","journal-title":"Surgery."},{"issue":"6","key":"17747_CR38","volume":"9","author":"SY Ha","year":"2014","unstructured":"Ha SY, Yeo SY, Xuan YH, Kim SH. The prognostic significance of cancer-associated fibroblasts in esophageal squamous cell carcinoma. PLoS ONE. 2014;9(6):e99955.","journal-title":"PLoS ONE."},{"issue":"4","key":"17747_CR39","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/bjc.2011.610","volume":"106","author":"S Dutta","year":"2012","unstructured":"Dutta S, Going JJ, Crumley ABC, et al. The relationship between tumour necrosis, tumour proliferation, local and systemic inflammation, microvessel density and survival in patients undergoing potentially curative resection of oesophageal adenocarcinoma. Br J Cancer. 2012;106(4):702\u201310.","journal-title":"Br J Cancer."},{"issue":"7","key":"17747_CR40","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0046-8177(99)90135-1","volume":"30","author":"C Torres","year":"1999","unstructured":"Torres C, Wang H, Turner J, Shahsafaei A, Odze RD. Prognostic significance and effect of chemoradiotherapy on microvessel density (angiogenesis) in esophageal Barrett\u2019s esophagus-associated adenocarcinoma and squamous cell carcinoma. Hum Pathol. 1999;30(7):753\u20138.","journal-title":"Hum Pathol."},{"issue":"1","key":"17747_CR41","first-page":"124","volume":"8","author":"S Hironaka","year":"2002","unstructured":"Hironaka S, Hasebe T, Kamijo T, et al. Biopsy specimen microvessel density is a useful prognostic marker in patients with T 2\u20134 M 0 esophageal cancer treated with chemoradiotherapy 1. Clin Cancer Res. 2002;8(1):124\u201330.","journal-title":"Clin Cancer Res."},{"issue":"6","key":"17747_CR42","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1158\/1078-0432.CCR-05-1982","volume":"12","author":"SC Zhang","year":"2006","unstructured":"Zhang SC, Hironaka S, Ohtsu A, et al. Computer-assisted analysis of biopsy specimen microvessels predicts the outcome of esophageal cancers treated with chemoradiotherapy. Clin Cancer Res. 2006;12(6):1735\u201342.","journal-title":"Clin Cancer Res."},{"issue":"5","key":"17747_CR43","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2559.2005.02142.x","volume":"46","author":"S Sharma","year":"2005","unstructured":"Sharma S, Sharma MC, Sarkar C. Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology. 2005;46(5):481\u20139.","journal-title":"Histopathology."},{"issue":"4","key":"17747_CR44","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/jcp.2002.004978","volume":"57","author":"J Laitakari","year":"2004","unstructured":"Laitakari J, N\u00e4yh\u00e4 V, Stenb\u00e4ck F. Size, shape, structure, and direction of angiogenesis in laryngeal tumour development. J Clin Pathol. 2004;57(4):394\u2013401.","journal-title":"J Clin Pathol."},{"issue":"8","key":"17747_CR45","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/ajh.21745","volume":"85","author":"A Raza","year":"2010","unstructured":"Raza A, Franklin MJ, Dudek AZ. Pericytes and vessel maturation during tumor angiogenesis and metastasis. Am J Hematol. 2010;85(8):593\u20138.","journal-title":"Am J Hematol."},{"issue":"3","key":"17747_CR46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000362276","volume":"51","author":"PC Stapor","year":"2014","unstructured":"Stapor PC, Sweat RS, Dashti DC, Betancourt AM, Murfee WL. Pericyte dynamics during angiogenesis: new insights from new identities. J Vasc Res. 2014;51(3):163\u201374.","journal-title":"J Vasc Res."},{"issue":"2","key":"17747_CR47","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1172\/JCI5028","volume":"103","author":"LE Benjamin","year":"1999","unstructured":"Benjamin LE, Golijanin D, Itin A, Pode D, Keshet E. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Investig. 1999;103(2):159\u201365.","journal-title":"J Clin Investig."},{"issue":"3","key":"17747_CR48","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.3390\/cancers3033405","volume":"3","author":"P Tonino","year":"2011","unstructured":"Tonino P, Abreu C. Microvessel density is associated with VEGF and \u03b1-SMA expression in different regions of human gastrointestinal carcinomas. Cancers (Basel). 2011;3(3):3405\u201318.","journal-title":"Cancers (Basel)."},{"issue":"5","key":"17747_CR49","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s00268-003-6866-2","volume":"27","author":"Y Ogata","year":"2003","unstructured":"Ogata Y, Fujita H, Yamana H, Sueyoshi S, Shirouzu K. Expression of vascular endothelial growth factor as a prognostic factor in node-positive squamous cell carcinoma in the thoracic esophagus: long-term follow-up study. World J Surg. 2003;27(5):584\u20139.","journal-title":"World J Surg."},{"issue":"2","key":"17747_CR50","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/(SICI)1097-0142(19970115)79:2<206::AID-CNCR2>3.0.CO;2-I","volume":"79","author":"K Inoue","year":"1997","unstructured":"Inoue K, Ozeki Y, Suganuma T, Sugiura Y, Tanaka S. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma: association with angiogenesis and tumor progression. Cancer. 1997;79(2):206\u201313.","journal-title":"Cancer."},{"issue":"10","key":"17747_CR51","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/bjc.1998.281","volume":"77","author":"S Uchida","year":"1998","unstructured":"Uchida S, Shimada Y, Watanabe G, et al. In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis. Br J Cancer. 1998;77(10):1704\u20139.","journal-title":"Br J Cancer."},{"issue":"7","key":"17747_CR52","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00432-003-0457-3","volume":"129","author":"T Mukherjee","year":"2003","unstructured":"Mukherjee T, Kumar A, Mathur M, Chattopadhyay TK, Ralhan R. Ets-1 and VEGF expression correlates with tumor angiogenesis, lymph node metastasis, and patient survival in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2003;129(7):430\u20136.","journal-title":"J Cancer Res Clin Oncol."},{"issue":"4","key":"17747_CR53","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3346\/jkms.2011.26.4.513","volume":"26","author":"MS Yoon","year":"2011","unstructured":"Yoon MS, Nam TK, Lee JS, et al. VEGF as a predictor for response to definitive chemoradiotherapy and COX-2 as a prognosticator for survival in esophageal squamous cell carcinoma. J Korean Med Sci. 2011;26(4):513\u201320.","journal-title":"J Korean Med Sci."},{"issue":"2","key":"17747_CR54","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1046\/j.1442-2050.2003.00309.x","volume":"16","author":"AR Rosa","year":"2003","unstructured":"Rosa AR, Schirmer CC, Gurski RR, Meurer L, Edelweiss MI, Kruel CD. Prognostic value of p53 protein expression and vascular endothelial growth factor expression in resected squamous cell carcinoma of the esophagus. Dis Esophagus. 2003;16(2):112\u20138.","journal-title":"Dis Esophagus."},{"issue":"1","key":"17747_CR55","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","volume":"26","author":"Y Chen","year":"2019","unstructured":"Chen Y, Song Y, Du W, Gong L, Chang H, Zou Z. Tumor-associated macrophages: an accomplice in solid tumor progression. J Biomed Sci. 2019;26(1):78.","journal-title":"J Biomed Sci."},{"issue":"11","key":"17747_CR56","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrclinonc.2010.139","volume":"7","author":"RK Jain","year":"2010","unstructured":"Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol. 2010;7(11):653\u201364.","journal-title":"Nat Rev Clin Oncol."},{"issue":"3","key":"17747_CR57","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1470-2045(17)30043-8","volume":"18","author":"D Cunningham","year":"2017","unstructured":"Cunningham D, Stenning SP, Smyth EC, et al. Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2\u20133 trial. Lancet Oncol. 2017;18(3):357\u201370.","journal-title":"Lancet Oncol."},{"issue":"6","key":"17747_CR58","doi-asserted-by":"crossref","first-page":"828","DOI":"10.21037\/jgo.2016.08.09","volume":"7","author":"GY Ku","year":"2016","unstructured":"Ku GY, Bains MS, Park DJ, et al. Phase II study of bevacizumab and preoperative chemoradiation for esophageal adenocarcinoma. J Gastrointest Oncol. 2016;7(6):828\u201337.","journal-title":"J Gastrointest Oncol."},{"key":"17747_CR59","doi-asserted-by":"crossref","first-page":"2317181","DOI":"10.1155\/2022\/2317181","volume":"2022","author":"J Wang","year":"2022","unstructured":"Wang J, Zhao Q, Cai L, Li J, Chen S. Efficacy of bevacizumab and gemcitabine in combination with cisplatin in the treatment of esophageal cancer and the effect on the incidence of adverse reactions. Biomed Res Int. 2022;2022:2317181.","journal-title":"Biomed Res Int."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17747-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17747-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17747-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T14:06:21Z","timestamp":1758549981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17747-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["17747"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17747-2","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study received approval from the Ethical Review Board of Okayama University on 4 November 2022 (Approval No. 1801-023; Okayama, Japan). An opt-out method was used. Our study plan was posted on the website\n                      \n                      . The research subjects who refused to participate in this study were not enrolled.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declared that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}